Back
Immutep Limited IMMP · Insights
Immutep Limited, a biotechnology company, engages in developing novel Lymphocyte Activation Gene-3 r... Price3.8
Market Cap29.04 M
Float7.19 M
CountryAU
SectorHealthcare
ExchangeNASDAQ
OverviewFilingsInsightsDilutionNewsTranscriptsInsights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro